Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome

Satoshi Saida, MD PhD, Masahiro Nakamura, MD PhD, Tsutomu Toki, PhD, Yoko Nishinaka-Arai, PhD, Kiminori Terui, MDPhD, Kenichi Yoshida, MD PhD, Seishi Ogawa, MD PhD, Tatsutoshi Nakahata, MD PhD, Toshio Heike, MD PhD, Ken-ichiro Watanabe, MD PhD, Akira Watanabe, PhD, Etsuro Ito, MD PhD

Blood (2015) 126 (23): 89.

https://doi.org/10.1182/blood.V126.23.89.89

Published: 2015

Journal Articles

Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

Nao Yoshida, MD PhD, Hiromasa Yabe, MD PhD, Kazuko Kudo, MDPhD, Ryoji Kobayashi, MD PhD, Miharu Yabe, MD PhD, Masami Inoue, MD, Mizuka Miki, MD PhD, Hisashi Sakamaki, MDPhD, Koji Kato, MDPhD, Keisei Kawa, MD PhD, Ritsuro Suzuki, MD PhD, Ken-ichiro Watanabe, MD PhD, Seiji Kojima, MD PhD

Blood (2014) 124 (21): 2559.

https://doi.org/10.1182/blood.V124.21.2559.2559

Published: 2014

Journal Articles

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Chitose Ogawa, MD, Atsushi Manabe, MD PhD, Hiroaki Goto, MD PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD PhD, Keitaro Fukushima, MD PhD, Ken-ichiro Watanabe, MD PhD, Keizo Horibe, MD, Atsushi Kikuta, MD PhD, Mitsuma Hamada, PhD, Akira Ohara, MD PhD

Blood (2014) 124 (21): 3657.

https://doi.org/10.1182/blood.V124.21.3657.3657

Published: 2014

Journal Articles

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Satoshi Saida, MD, Itaru Kato, MD, Takeshi Inukai, MD, PhD, Atsushi Nemoto, MD, PhD, Kanji Sugita, MD, PhD, Yasuhiro Maeda, MD, PhD, Akira Niwa, MD, PhD, Ken-ichiro Watanabe, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Toshio Heike, MD, PhD

Blood (2011) 118 (21): 2577.

https://doi.org/10.1182/blood.V118.21.2577.2577

Published: 2011

Journal Articles

Reduced Production of Mature Neutrophils From Induced Pluripotent Stem Cells Derived From a Severe Congenital Neutropenia Patient with HAX1 Gene Deficiency

Tatsuya Morishima, MD, Ken-ichiro Watanabe, MD, PhD, Akira Niwa, MD, PhD, Takayuki Tanaka, MD, Katsutsugu Umeda, MD, PhD, Hidefumi Hiramatsu, MD, PhD, Kousaku Matsubara, MD, PhD, Souichi Adachi, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Toshio Heike, MD, PhD

Blood (2011) 118 (21): 2402.

https://doi.org/10.1182/blood.V118.21.2402.2402

Published: 2011

Journal Articles

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Yuri Kamitsuji, MD, Souichi Adachi, MD, PhD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Ken-Ichiro Watanabe, MD, PhD, Hideo Tanaka, MD, PhD, Junya Kuroda, MD, PhD, Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, Tatsutoshi Nakahata, MD, PhD

Blood (2006) 108 (11): 2177.

https://doi.org/10.1182/blood.V108.11.2177.2177

Published: 2006

Journal Articles

Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.

Ken-ichiro Watanabe, MD, Yigal Dror, MD

Blood (2005) 106 (11): 386.

https://doi.org/10.1182/blood.V106.11.386.386

Published: 2005

NARROW

Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome

Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Reduced Production of Mature Neutrophils From Induced Pluripotent Stem Cells Derived From a Severe Congenital Neutropenia Patient with HAX1 Gene Deficiency

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.

Email alerts

ASH Publications

American Society of Hematology

Dysregulation of DNA Methylation Involves in Progression of Myeloid Leukemia in Down Syndrome

Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Reduced Production of Mature Neutrophils From Induced Pluripotent Stem Cells Derived From a Severe Congenital Neutropenia Patient with HAX1 Gene Deficiency

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only